Multiple Keratoacanthoma-like Syndromes: Case Report and Literature Review.
Karampinis E, Kostopoulou C, Toli O, Marinos L, Papadimitriou G, Roussaki Schulze AV, Zafiriou E.
Medicina (Kaunas). 2024 Feb 22;60(3):371. doi: 10.3390/medicina60030371.
Vulvar keratoacanthoma.
Ozkan F, Bilgiç R, Cesur S.
APMIS. 2006 Jul-Aug;114(7-8):562-5. doi: 10.1111/j.1600-0463.2006.apm_326.x.
Differentiating keratoacanthoma from squamous cell carcinoma-In quest of the holy grail.
Nagarajan P.
J Cutan Pathol. 2020 Apr;47(4):418-420. doi: 10.1111/cup.13640. Epub 2020 Jan 14.
Keratoacanthoma clinical behavior: a systematic review.
Savage JA, Maize JC Sr.
Am J Dermatopathol. 2014 May;36(5):422-9. doi: 10.1097/DAD.0000000000000031.
Eruptive keratoacanthoma secondary to immune checkpoint inhibitors: a narrative review.
Mager L, Plaza JA, Sopkovich J, Kaffenberger BH, Dulmage B.
Arch Dermatol Res. 2025 Jan 13;317(1):234. doi: 10.1007/s00403-024-03694-7.
Keratoacanthoma, committed stem cells and neoplastic aberrant infundibulogenesis integral to formulating a conceptual model for an infundibulocystic pathway to squamous cell carcinoma.
Kossard S.
J Cutan Pathol. 2021 Jan;48(1):184-191. doi: 10.1111/cup.13861. Epub 2020 Oct 16.
Subungual keratoacanthoma.
Levy DW, Bonakdarpour A, Putong PB, Mesgarzadeh M, Betz RR.
Skeletal Radiol. 1985;13(4):287-90. doi: 10.1007/BF00355351.
Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma?
Mandrell JC, Santa Cruz D.
Semin Diagn Pathol. 2009 Aug;26(3):150-63. doi: 10.1053/j.semdp.2009.09.003.
Subungual keratoacanthoma.
Stoll DM, Ackerman AB.
Am J Dermatopathol. 1980 Fall;2(3):265-71. doi: 10.1097/00000372-198000230-00017.
Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma.
Beham A, Regauer S, Soyer HP, Beham-Schmid C.
Adv Anat Pathol. 1998 Sep;5(5):269-80.
